Sign In

Clifford Stocks

Chief Executive Officer at OncoResponse, Inc.

Clifford J. Stocks is the Founder and Chief Executive Officer of OncoResponse Inc., a clinical-stage, immuno-oncology biotech company developing cancer immunotherapies.13 He has been in this role since October 2015, bringing over 30 years of experience in the biotech industry.23

Prior to founding OncoResponse, Stocks served as:

  1. Chief Executive Officer at Theraclone Sciences, Inc. (December 2011 - May 2016)3
  2. Chief Business Officer at Calistoga Pharmaceuticals (March 2009 - April 2011)3
  3. Vice President of Business Development at ICOS Corporation (February 1992 - February 2007)3

Stocks played a key role in several significant business transactions, including:

  • Leading the acquisition of Calistoga Pharmaceuticals by Gilead for $600 million in 201112
  • Contributing to the $2.3 billion acquisition of ICOS Corporation by Lilly in 200713

His educational background includes:

  • Master of Business Administration from the University of Chicago, Booth Graduate School of Business12
  • Bachelor of Science degree in Biology from the University of Utah14

At OncoResponse, Stocks leads the company's efforts to develop novel therapeutics targeting the tumor microenvironment, using a proprietary B-cell discovery platform in collaboration with MD Anderson Cancer Center.3

Related Questions

What are Clifford Stocks' key achievements at Theraclone Sciences?
How did Clifford Stocks contribute to the acquisition of Calistoga by Gilead?
What was Clifford Stocks' role in the development and launch of Cialis?
What are Clifford Stocks' educational background and early career?
How has Clifford Stocks' experience at ICOS Corporation influenced his leadership at OncoResponse?
Clifford Stocks
Clifford Stocks, photo 1
Clifford Stocks, photo 2
Add to my network

Location

Seattle, Washington, United States